US2022322977A1PendingUtilityA1

Dual electrode system for a continuous analyte sensor

Assignee: DEXCOM INCPriority: Oct 4, 2006Filed: Jun 24, 2022Published: Oct 13, 2022
Est. expiryOct 4, 2026(~0.2 yrs left)· nominal 20-yr term from priority
A61B 5/14532A61B 5/6849C12Q 1/006A61B 5/14865A61B 5/1486
77
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed herein are systems and methods for a continuous analyte sensor, such as a continuous glucose sensor. One such system utilizes first and second working electrodes to measure additional analyte or non-analyte related signal. Such measurements may provide a background and/or sensitivity measurement(s) for use in processing sensor data and may be used to trigger events such as digital filtering of data or suspending display of data.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . An analyte monitoring system, comprising:
 a sensor, comprising:
 a first sensing region configured to generate a first signal associated with a concentration of a first analyte; 
 a second sensing region configured to generate a second signal associated with a concentration of a second analyte, the second analyte being different than the first; 
 a first oxygen flux-controlling domain positioned over the first sensing region; 
 a second oxygen flux-controlling domain positioned over the formed over the second sensing region; and 
 a shared oxygen flux-controlling domain positioned over the first sensing region and the second sensing region. 
   
     
     
         2 . The system of  claim 1 , further comprising a first enzyme domain positioned on the first sensing region and a second enzyme domain positioned on the second sensing region. 
     
     
         3 . The system of  claim 2 , wherein the first enzyme domain and the second enzyme domain are each configured to generate a measurable species. 
     
     
         4 . The system of  claim 3 , wherein the measurable species comprises H 2 O 2  produced in each of the first enzyme domain and the second enzyme domain of the sensor membrane. 
     
     
         5 . The system of  claim 1 , wherein the oxygen flux-controlling domain is configured to provide a physical diffusion barrier. 
     
     
         6 . The system of  claim 5 , wherein the physical diffusion barrier is configured to physically block some crosstalk between the first sensing region and the second sensing regions. 
     
     
         7 . The system of  claim 3 , wherein the first sensing region and the second sensing region are spaced closer together than a crosstalk distance of the measurable species. 
     
     
         8 . The system of  claim 1 , wherein the first sensing region is configured to measure glucose. glucose and the second sensing region is configured to measure lactate. 
     
     
         9 . The system of  claim 1 , wherein the first sensing region is configured to measure glucose and the second sensing region is configured to measure another analyte, wherein the other analyte is not glucose. 
     
     
         10 . The system of  claim 1 , wherein the first enzyme is glucose oxidase. 
     
     
         11 . The system of  claim 1 , wherein the first analyte is glucose. 
     
     
         12 . The system of  claim 1 , wherein the second analyte comprises cholesterol, lactate, urea, bilirubin, uric acid, or creatinine. 
     
     
         13 . The system of  claim 1 , wherein the second analyte comprises triglycerides. 
     
     
         14 . The sensor of  claim 1 , wherein the first analyte is glucose and the second analyte is lactate. 
     
     
         15 . An analyte monitoring system, comprising:
 a sensor, comprising:
 a first sensing region configured to generate a first signal associated with a concentration of a first analyte; 
 a second sensing region configured to generate a second signal associated with a concentration of a second analyte, the second analyte being different than the first; and 
 a shared oxygen flux-controlling domain positioned over the first sensing region and the second sensing region. 
   
     
     
         16 . The system of  claim 15 , further comprising a first oxygen flux-controlling domain positioned over the first sensing region and a second oxygen flux-controlling domain positioned over the formed over the second sensing region. 
     
     
         17 . The system of  claim 15 , wherein the second analyte comprises cholesterol, lactate, urea, bilirubin, uric acid, or creatinine. 
     
     
         18 . The system of  claim 15 , wherein the second analyte comprises triglycerides. 
     
     
         19 . The sensor of  claim 15 , wherein the first analyte is glucose and the second analyte is lactate. 
     
     
         20 . The sensor of  claim 15 , wherein the first analyte is glucose and the second analyte is uric acid.

Join the waitlist — get patent alerts

Track US2022322977A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.